MTHFD2 is relatively lowly expressed in normal tissues [47] and is upregulated in different cancers, including breast, colorectal, and hepatocellular cancers, where it plays a key role in remodeling the folate metabolism of tumor cells [48]. Here, MTHFD2 is linked to hepatocellular carcinoma.